Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 870, Issue 2, 2008, Pages 192-202

  Wu, Ya Hsueh ^a   Lin, Keh liang ^a   Chen, Su Chin ^b   Chang, Yan Zin ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Drugs of abuse; Hair testing; Multiple ionization; Simultaneous

Indexed keywords

ACID ANHYDRIDES; AMPHETAMINE (AM); DRUGS OF ABUSE; ELECTRON IMPACT-IONIZATION; ELSEVIER (CO); GAS CHROMATOGRAPHY/MASS SPECTROMETRY (GC/MS); HIGH SENSITIVITY (HS); HUMAN HAIRS; KETAMINE; LIMIT-OF-DETECTION (LOD); METHAMPHETAMINE (MEAM); MULTIPLE IONIZATION; NEGATIVE CHEMICAL IONIZATION (NCI); NEW STRATEGY; NORKETAMINE; QUANTITATIVE DETERMINATIONS; SOLID PHASE EXTRACTION (SPE); TRIFLUOROACETIC ACID (TFA);

AMINES; AMPLITUDE MODULATION; BROADBAND AMPLIFIERS; CHEMICAL OXYGEN DEMAND; CHEMOTHERAPY; CHROMATOGRAPHIC ANALYSIS; DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS; EXTRACTION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTEGRATION; IONIZATION; IONIZATION OF GASES; MASS SPECTROMETRY; METHANOL; SENSITIVITY ANALYSIS; SOLVENT EXTRACTION;

IMPACT IONIZATION;

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BUTYRIC ACID DERIVATIVE; CODEINE; HEPTAFLUOROBUTYRIC ACID ANHYDRIDE; KETAMINE; METHAMPHETAMINE; METHANOL; METHYLENEDIOXY ETHYLAMPHETAMINE; MORPHINE; MORPHINE 6 ACETATE; OPIATE DERIVATIVE; TRIFLUOROACETIC ACID;

ANALYTIC METHOD; ARTICLE; DERIVATIZATION; DRUG ABUSE; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HUMAN; INTERMETHOD COMPARISON; METABOLITE; NEGATIVE CHEMICAL IONIZATION MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION;

AMPHETAMINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HAIR; HUMANS; KETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OPIATE ALKALOIDS; SUBSTANCE ABUSE DETECTION;

EID: 47249160196     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.06.017     Document Type: Article

References (29)

1. Dolan K., Rouen D., and Kimber J. Drug Alcohol Rev. 23 (2004) 213
2. Pragst F., and Balikova M.A. Clin. Chim. Acta 370 (2006) 17
3. Boumba V.A., Ziavrou K.S., and Vougiouklakis T. Int. J. Toxicol. 25 (2006) 143
4. Jurado C., Gimenez M.P., Menendez M., and Repetto M. Forensic Sci. Int. 70 (1995) 165
5. Pichini S., Poudevida S., Pujadas M., Menoyo E., Pacifici R., Farré M., and de la Torre R. Ther. Drug Monit. 28 (2006) 106
6. Kłys M., Rojek S., Kulikowska J., Bożek E., and Scisłowski M. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 854 (2007) 299
7. Clauwaert K.M., Van Bocxlaer J.F., Lambert W.E., and De Leenheer A.P. Forensic Sci. Int. 110 (2000) 157
8. Wennig R. Forensic Sci. Int. 107 (2000) 5
9. Stout P.R., Ropero-Miller J.D., Baylor M.R., and Mitchell J.M. J. Anal. Toxicol. 30 (2006) 490
10. Thorspecken J., Skopp G., and Pötsch L. Clin. Chem. 50 (2004) 596
11. Romano G., Barbera N., Spadaro G., and Valenti V. Forensic Sci. Int. 131 (2003) 98
12. Skopp G., Potsch L., and Moller M.R. Forensic Sci. Int. 84 (1997) 43
13. Rollins D.E., Wilkins D.G., Krueger G.G., Augsburger M.P., Mizuno A., O'Neal C., Borges C.R., and Slawson M.H. J. Anal. Toxicol. 27 (2003) 545
14. Gautam L., Scott K.S., and Cole M.D. J. Anal. Toxicol. 29 (2005) 339
15. Kintz P., and Mangin P. Forensic Sci. Int. 73 (1995) 93
16. Gaillard Y., and Pepin G. Forensic Sci. Int. 86 (1997) 49
17. Romolo F.S., Rotolo M.C., Palmi I., Pacifici R., and Lopez A. Forensic Sci. Int. 138 (2003) 17
18. Skender L., Karacic V., Brcic I., and Bagaric A. Forensic Sci. Int. 125 (2002) 120
19. Kintz P., Cirimele V., Tracqui A., and Mangin P. J. Chromatogr. B Biomed. Sci. Appl. 670 (1995) 162
20. Rohrich J., and Kauert G. Forensic Sci. Int. 84 (1997) 179
21. Villamor J.L., Bermejo A.M., Fernandez P., and Tabernero M.J. J. Anal. Toxicol. 29 (2005) 135
22. Maurer H.H. Ther. Drug Monit. 24 (2002) 247
23. Acampora A., Della Casa.E., Martone G., and Miraglia N. J. Mass Spectrom. 38 (2003) 1007
24. Martins L., Yegles M., Chung H., and Wennig R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 (2005) 57
25. Van Bocxlaer J.F., Clauwaert K.M., Lambert W.E., Deforce D.L., Van den Eeckhout E.G., and De Leenheer A.P. Mass Spectrom. Rev. 19 (2000) 165
26. Scheidweiler K.B., and Huestis M.A. Anal. Chem. 76 (2004) 4358
27. Wu Y.H., Lin K.L., Chen S.C., and Chang Y.Z. Rapid Commun. Mass Spectrom. 22 (2008) 887
28. Segura J., Ventura R., and Jurado C. J. Chromatogr. B Biomed. Sci. Appl. 713 (1998) 61
29. Mandatory guidelines for FederalWorkplace Drug Testing Programs. SAMHSA. 1994. HHS.